# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-266928
Filing Date
2025-11-05
Accepted
2025-11-05 16:10:00
Documents
13
Period of Report
2025-12-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | acet-20251105.htm iXBRL | PRE 14A | 323336
2 | GRAPHIC | img106677922_0.jpg | GRAPHIC | 11570
3 | GRAPHIC | img106677922_1.jpg | GRAPHIC | 195159
4 | GRAPHIC | img106677922_2.jpg | GRAPHIC | 235803
| Complete submission text file | 0001193125-25-266928.txt |  | 1681235

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acet-20251105.xsd | EX-101.SCH | 40863
15 | EXTRACTED XBRL INSTANCE DOCUMENT | acet-20251105_htm.xml | XML | 1293

Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38359 | Film No.: 251454031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)